Abordaje diagnóstico y terapéutico de la dispepsia en atención primaria

Amador Romero, 1996, Úlcera péptica. Recomendaciones semFYC

1998, The role of endoscopy in the surveillance of premalignant conditions of the upper gastrointestinal tract, Gastrointestinal Endoscopy, 48, 663, 10.1016/S0016-5107(98)70055-0

Badia, 1999, Análisis coste-efectividad de estrategias de diagnóstico-tratamiento del ulcus péptico asociados a Helicobacter pylori en atención primaria, Aten Primaria, 24, 344

Barcenilla Laguna, 2000, Esofagitis, Medicine, 8, 14

Boixeda, 1995, ¿Existe alguna relación entre la sintomatología digestiva y la infección por Helicobacter pylori?, Rev Esp Enf Dig, 87, 8

Breuer, 1998, How do clinicians practicing in the U.S. manage Helicobacter pylori-related gastrointestinal diseases? A comparison of primary care and specialist physicians, Am J Gastroenterol, 93, 553, 10.1111/j.1572-0241.1998.164_b.x

1996, BSG Clinical Guidelines in Gastroenterology: Dyspepsia Management Guidelines, Septiembre

Brown, 1990, Dyspepsia in general practice, BJM, 300, 829, 10.1136/bmj.300.6728.829

Carvajal, 1999, Consumo de fármacos antiulcerosos en España, Aten Primaria, 23, 218

De Vault, 1995, O. Guidelines for the diagnosis and treatment of gastroesophageal reflux disease. Practice parameters Committee the American College of Gastroenterology, Arch Intern Med, 155, 2165, 10.1001/archinte.1995.00430200044008

Drossman, 1990, E. Identification of subgroups of funtional intestinal disorders, Gastroenterology Int, 3, 159

Elizalde Frez, 2000, Tratamiento médico de la enfermedad ulcerosa péptica, Medicine, 8, 134

Ferrándiz Santos, 2000, Dispepsia, FMC, 7, 9

Caballé, 2000, Complicaciones de la enfermedad ulcerosa péptica: manifestaciones clínicas, actitudes diagnósticas e indicaciones terapéuticas, Medicine, 8, 128

Galindo, 1998, Gases y digestiones pesadas, 569

Galindo, 1998, Dolor abdominal recidivante, 584

Gisbert, 2000, y Grupo de la Conferencia Española de Consenso sobre Helicobacter pylori, Med Clin (Barc), 114, 185, 10.1016/S0025-7753(00)71237-1

Gisbert, 1998, Recurrence of Helicobacter pylori infection after eradication: incidence and variables influencing it, Scand J Gastroenterol, 33, 1144, 10.1080/00365529850172485

Goyeneche Gracia, 2000, Patología esofágica por reflujo: mecanismos etiopatogénicos, manifestaciones clínicas, complicaciones y criterios diagnósticos, Medicine, 8, 23

Hallas, 1995, Nonsteroidal anti-inflammatory drugs and upper gastointestinal bleeding, identifying highrisk groups by excess risk estimates, Scand J Gastroenterol, 30, 438, 10.3109/00365529509093304

Huang, 1999, The importance of clarithromycin dose in the management of Helicobacter pylori infection: a meta-analysis of triple therapies with a proton pump inhibitor, clarithromycin and amoxycillin or metronidazole, Aliment Pharmacol Ther, 13, 719, 10.1046/j.1365-2036.1999.00530.x

Lanza, 1998, A guideline for the treatment and prevention of NSAID-induced ulcers, Am J Gastroenterol, 93, 2037, 10.1111/j.1572-0241.1998.00588.x

Madridejos Mora, 1999, Omeprazol y gastroprotección, Aten Primaria, 23, 441

Martín Alonso, 2000, Aspectos terapéuticos del reflujo gastroesofágico, Medicine, 8, 31

Meshkinpour, 1995, Esophageal aperistalsis and gastroesophageal reflux disorder: returm of peristalsis after H2-bloker therapy, Am J Gastroenterol, 90, 910

Ofman, 1997, Management strategies for Helicobacter pylori-seropositive patients with dyspepsia: clinical and economic consequences, Ann Intern Med, 126, 280, 10.7326/0003-4819-126-4-199702150-00004

Ott, 1995, Association of hiatal hernia and gastroesophageal reflux: correlation between presence and size of hiatal hernia and 24-hour pH monitoring of the esophagus, Am J Roentgenol, 165, 557, 10.2214/ajr.165.3.7645469

Pimentel Leal, 1996, López Carabaño A. Prevención de la hemorragia digestiva durante la administración de antiinflamatorios no esteroideos, FMC, 9, 131

Pujol Farriols, 1999, Patología digestiva, 1253

Rábago Torre, 1998, Estudio y tratamiento del paciente con meteorismo, FMC, 2, 104

Rubin, 1999, The management of Helicobacter pylori infection in primary care. Guidelines from the ESPCG, Eur J Gen Pract, 5, 98, 10.3109/13814789909094271

Sans Cuffí, 2000, Enfermedad ulcerosa péptica: etiopatogenia, clasificación, manifestaciones clínicas y diagnóstico, Medicine, 8, 121

Sans Cuffí, 2000, Protocolo diagnóstico de la dispepsia, Medicine, 8, 89

Smith, 1998, Sensivity of the esofageal mucosa to pH in gastroesophageal reflux disease, Gastroenterology, 96, 683, 10.1016/S0016-5085(89)80065-4

Solans Laqué, 1999, Patología digestiva en el anciano. Aspectos característicos, Medicine, 7, 5866

Talley, 1998, AGA technical review: evaluation of dyspepsia, Gastroenterology, 114, 582, 10.1016/S0016-5085(98)70542-6

Talley, 1999, Absence of benefit of eradicating Helicobacter pylori in patients with non-ulcer dyspepsia, N Engl J Med, 341, 1106, 10.1056/NEJM199910073411502

1997, Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Report, Gut, 41, 8, 10.1136/gut.41.1.8

1997, Current European concepts in the management of Helicobacter pylori infection. The Maastricht Consensus Conference, Gut, 41, 8, 10.1136/gut.41.1.8

Vara, 1998, Pirosis y epigastralgia, 563

Vernet Vernet, 2000, Análisis de las indicaciones y diagnósticos de las gastroscopias solicitadas por médicos de atención primaria, Aten Primaria, 25, 253, 10.1016/S0212-6567(00)78496-4

Vigneri, 1995, A comparison of five maintenance therapies for reflux esophagitis, N Engl J Med, 333, 1106, 10.1056/NEJM199510263331703

Yeomans, 1998, A comparison of omeprazole with ranitidine for ulcers associated with nonsteroidal antiinflammatory drugs, N Engl J Med, 338, 719, 10.1056/NEJM199803123381104